Biosency has raised funds for further development
Biosency has completed a fundraising to develop a software for predictive diagnosis.
Biosency is a French MedTech company focused on changing the way clinicians and patients manage chronic obstructive pulmonary disease (COPD). The company provides innovative, connected and patient-focused remote monitoring solutions to analyze long-term trends of vital signs which are of critical importance to reduce readmission rates by adjusting medication.
Oaklins’ team in France acted as the exclusive advisor to Biosency.
Talk to the deal team
Senior AdvisorParis, France
Westminster Homecare has been acquired by Care at Home
The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.Learn more
RVC Medical IT has been acquired by NEXUS AG
Main Capital Partners B.V. has sold RVC Medical IT B.V. to NEXUS AG.Learn more
SCS Computers has been acquired by MAPS Group
The private shareholders of SCS Computers, an Italian software company specialized in the healthcare sector, have sold the company to MAPS Group.Learn more